Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform

RESTON, Va., June 28, 2011 /PRNewswire/ -- The Mirixa Corporation and the Canadian Association of Chain Drug Stores (CACDS) are pleased to announce that MirixaPro(SM), a Web-based clinical platform that supports and documents standardized, pharmacy-based patient care service delivery, will be deployed in Canada. The two organizations signed a 10-year licensing agreement enabling CACDS to use a scalable, localized version of the MirixaPro platform.

(Logo:  http://photos.prnewswire.com/prnh/20100818/SF51721LOGO)

CACDS members represent more than 6,200 pharmacies and dispense 70% of Canada's prescriptions each year. The deployment of MirixaPro will enable Canada's most active pharmacies to more efficiently augment their dispensing services with enhanced pharmacy services including comprehensive medication management. MirixaPro will enable pharmacists to document patient progress, identify compliance issues, and supply educational materials. This information can then be shared with patients' other care providers, fostering greater care and inter-professional collaboration and ultimately optimizing health outcomes.

Nadine Saby, President and CEO of CACDS comments, "Community pharmacy in Canada is in the early stages of significant professional practice evolution and payers are moving to establish reimbursement for these new pharmacy services, recognizing the value in improved patient health and well-being and cost effectiveness to the health care system. To better enable the delivery of these services, CACDS looked for a tool that would help standardize the deployment of clinical pharmacy services across the country through the use of a common technology platform. We evaluated a number of solutions and were impressed with the strength of the MirixaPro platform and the robustness of its capabilities."

"Worldwide, patient engagement is considered a necessary component for improved patient health outcomes," notes Rick Solano, CEO of Mirixa. "We are delighted that MirixaPro will be an important vehicle used by Canadian pharmacists to actively engage their patients and expand the role of pharmacists within their communities. Our deployment of technology beyond the U.S. demonstrated to CACDS leadership that the MirixaPro platform could be adapted to local needs and support an expanded set of requirements well into the future."

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

About CACDS

CACDS is the national association that represents the community pharmacy industry in Canada. The retail members of CACDS are traditional chain and banner drug stores, grocery chains and mass merchandisers with pharmacies. CACDS associate members include companies representing all product categories and service suppliers to the drug store industry.

CACDS provides its members with a wide range of services, including authoritative research and discussion forums on industry trends, representation of industry viewpoints to governments, stakeholders and the public, and co-operative initiatives with related industry sectors - all in the interest of enhancing the value of community pharmacy to consumers. Visit online at www.cacds.com

SOURCE Mirixa Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED